|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.680 USD | +1.82% |
|
-2.89% | +18.31% |
| 03-10 | Coherus Oncology, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 | CI |
| 03-10 | Coherus Oncology, Inc., Q4 2025 Earnings Call, Mar 09, 2026 |
| Capitalization | 252M 215M 199M 187M 348M 23.42B 355M 2.33B 911M 11.25B 945M 925M 40.07B | P/E ratio 2026 * |
-1.75x | P/E ratio 2027 * | -1.83x |
|---|---|---|---|---|---|
| Enterprise value | 252M 215M 199M 187M 348M 23.42B 355M 2.33B 911M 11.25B 945M 925M 40.07B | EV / Sales 2026 * |
2.98x | EV / Sales 2027 * | 2.24x |
| Free-Float |
95.98% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Coherus Oncology, Inc.
| 1 day | +1.82% | ||
| 1 week | -2.89% | ||
| Current month | -0.59% | ||
| 1 month | -5.62% | ||
| 3 months | -0.59% | ||
| 6 months | +0.60% | ||
| Current year | +18.31% |
| 1 week | 1.59 |  | 1.78 |
| 1 month | 1.52 | | 1.85 |
| Current year | 1.35 | | 2.62 |
| 1 year | 0.71 | | 2.62 |
| 3 years | 0.66 | | 8.65 |
| 5 years | 0.66 | | 19.32 |
| 10 years | 0.66 | | 31.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Denny Lanfear
CEO | Chief Executive Officer | 70 | 01/09/2010 |
Bryan Mcmichael
DFI | Director of Finance/CFO | 48 | 08/12/2023 |
Rosh Dias
CTO | Chief Tech/Sci/R&D Officer | - | 15/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Mats Wahlström
BRD | Director/Board Member | 71 | 01/01/2012 |
Denny Lanfear
CHM | Chairman | 70 | 01/09/2010 |
Ali Satvat
BRD | Director/Board Member | 48 | 01/05/2014 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.82% | -2.89% | +100.98% | -78.46% | 252M | |
| -1.65% | +0.42% | +28.27% | +158.07% | 841B | |
| -1.18% | -1.88% | +57.16% | +45.16% | 574B | |
| -2.10% | -0.43% | +18.79% | +28.85% | 368B | |
| -0.09% | 0.00% | +30.43% | +16.21% | 320B | |
| -0.30% | -0.56% | +52.18% | +30.95% | 318B | |
| -1.03% | +0.46% | +53.35% | +7.94% | 300B | |
| -0.34% | -1.17% | +41.43% | +40.20% | 295B | |
| -1.29% | +0.89% | +22.74% | +39.61% | 189B | |
| -2.18% | -0.52% | +34.12% | +68.39% | 173B | |
| Average | -0.83% | -0.04% | +43.95% | +35.69% | 337.81B | |
| Weighted average by Cap. | -1.18% | +0.00% | +37.98% | +64.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 84.42M 71.91M 66.55M 62.67M 117M 7.85B 119M 781M 305M 3.77B 317M 310M 13.43B | 112M 95.79M 88.65M 83.47M 155M 10.46B 159M 1.04B 407M 5.02B 422M 413M 17.89B |
| Net income | -147M -125M -116M -109M -203M -13.66B -207M -1.36B -531M -6.56B -551M -539M -23.36B | -145M -124M -114M -108M -201M -13.5B -205M -1.34B -525M -6.48B -545M -533M -23.1B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/04/26 | 1.680 $ | +1.82% | 556,774 |
| 09/04/26 | 1.650 $ | -2.94% | 990,376 |
| 08/04/26 | 1.700 $ | +1.80% | 816,740 |
| 07/04/26 | 1.670 $ | 0.00% | 735,105 |
| 06/04/26 | 1.670 $ | -3.47% | 620,552 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CHRS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition